Myasthenia Gravis
Conditions
Brief summary
The purpose of this study is to create a Yale University Department of Neurology Myasthenia Gravis (MG) registry that will be used for current and future research projects involving the study of Myasthenia Gravis.
Detailed description
This registry will allow for the research of several mechanisms of Myasthenia Gravis (MG) by studying peripheral blood, stool, disease status and course, and treatment of subjects with MG. The EXPLORE-MG Registry focuses on varied aspects of MG such as disease management, health care utilization, health costs, disease characteristics, and diagnostic tools. As such, it will aid in a broader understanding of MG, while providing a registry from which questions about the disease may be better answered.
Interventions
Approximately 100 cc (less than 1/2 cup) of blood will be drawn from both groups.
Sponsors
Study design
Eligibility
Inclusion criteria
* Adult patients diagnosed with Myasthenia Gravis presenting to the Yale Department of Neurology for clinical care or research interventions will be invited to donate their biological specimens/clinical data.
Exclusion criteria
* Failure to meet the Inclusion Criteria.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| The number of successful blood draws will be reported at the conclusion of the sample collection | 8 years | Successful Collection of Blood |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| The number of stool samples collected will be reported at the conclusion of the sample | 8 years | Count of Stool Samples |
Countries
United States